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Overweight and obesity not only are major risk factors for number of chronic diseases, but also a risk factor for 
pregnancy complications in women. The present study aims to investigate the association between pre-pregnancy 
BMI and the persistence and duration of BF. The electronic databases including Medline (PubMed), Scopus, 
Embase, Web of Science and Google Scholar were searched for papers with titles and/or abstracts including one of 
our keywords and published up to 15 April 2019. For dose-response relationship, the two-stage random-effects 
meta-analysis was performed using the “dosresmeta” function in R software. Thirty-two studies with the effect of 
pre-pregnancy BMI on BF initiation, intention and duration were included in the present study. Based on crude 
and adjusted OR models, the risk of BF cessation increased by 4% (OR ¼ 1.04; 95% CI: 1.02–1.05) with an in-
crease in a unit of BMI. In addition, based on crude and adjusted RR models, the risk of BF cessation increases by 
2% and 1% (crude RR ¼ 1.02; 95% CI: 1.01–1.03 and adjusted RR ¼ 1.01; 95% CI: 0.99–1.02) with an increase in 
one unit of BMI. Based on the result, the health care professionals and other key stakeholders should be aware of 
the impact excess weight, and that women who are overweight or obese should be encouraged with continued 
access to guidance, counseling and support, starting from conception, to maximize BF outcomes. 1. Introduction 
Overweight and obesity are defined as abnormal or excess fat accu-
mulation, and are a risk for general health [1]. Given that the prevalence 
of obesity has increased, universally, it has become a global public health 
concern [2]. The prevalence of overweight and obesity has almost tripled 
between 1975 and 2016 and has reached an epidemic in the world. Ac-
cording to the world health organization (WHO) in 2016, more than 1.9 
billion adults were overweight and 650 million were obese. At least 2.8 di), farid_n32@yahoo.com (F. N
 September 2020; Accepted 25 N
vier Ltd. This is an open access amillion people each year die as a result of being overweight or obesity 
[3]. In the past, obesity was associated with high-income countries, 
however, it is now also prevalent in both low- and middle-income 
countries [4]. 
Overweight and obesity not only are major risk factors for the number 
of chronic diseases, including diabetes, cardiovascular diseases, and 
cancer, but also a risk factor for pregnancy complications in women [2]. 
According to recent studies; hypertension, preeclampsia, gestational 
diabetes, cesarean section, long delivery, intrauterine fetal death and ajafi). 
ovember 2020 
rticle under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 
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6]. Women with high body mass index (BMI) have delays in establishing 
lactation after giving birth. In addition, overweight and obesity increase 
the risk of early cessation of breastfeeding (BF) [7]. In fact, BF can reduce 
the risk of infectious disease and overweight and obesity among children 
[8]. The World Health Organization (WHO) recommends that exclusi-
ve/full breastfeeding (EBF) should continue to 6 months of age, with the 
gradual addition of complementary foods until 24 months of age [1]. 
Worldwide, about 45% of infants are breastfed within the first hour after 
birth, and data from 2011 to 2017 indicate that only 40% of infants 
between 0 and 6 months of age are exclusively breastfed [9]. According 
to data from WHO, 39% of women aged older than 18 years old were 
overweight around the world in 2016 [1,10]. Studies show that women 
with pre-pregnancy underweight, overweight, and obesity, are less likely 
to initiate breastfeeding and/or continue EBF and/or any breastfeeding 
(ABF) to recommended time [11, 12, 13, 14]. 
In current systematic reviews, women with pre-pregnancy over-
weight and obesity were less likely to initiate BF and continue with EBF. 
However, antecedent evidence does not consider a dose-response asso-
ciation between maternal BMI and EBF/ABF [8,15, 16, 17, 18]. There-
fore, in the present study, the association between pre-pregnancy body 
mass index and the persistence and duration of BF will be investigated in 
a systematic review and dose-response meta-analyses. 
2. Methods 
2.1. Search strategy 
Five electronic databases including Medline (PubMed), Scopus, 
Embase, Web of Science and Google Scholar were searched for papers 
with titles and/or abstracts including one of our keywords and published 
up to 15 April 2019. Different combinations of general keywords, MeSH 
and Emtree terms were: “BMI”, “Body Mass Index”, “Overweight”, 
“Obesity”, “Breast Feeding”, “Breast Feeding Initiation”, “Breast Feeding 
Intensity”, “Breast Feeding Duration”, “Cross-Sectional Studies”, “Cohort 
Studies”, “Case-Control Studies”, “Prospective Studies”, and “Retro-
spective Studies” (Appendix 1). Duplicate papers were checked and 
deleted. In addition, if the full-text of paper were unavailable, we 
requested the paper from the author via email. We used the abstracts of 
paper (if there were enough information and data) or papers were 
excluded from the study where the author did not answer. 2.2. Study selection 
All English observational studies on pre-pregnancy BMI and breast-
feeding initiation, intention and duration were included. The title and 
abstract of publications were screened. 
The criteria for inclusion of studies in the meta-analysis were: 
1. The study was included if enough information about pre-pregnancy 
BMI before significant weight gain was available. Therefore, all 
studies in which there was a record of first BMI within the first 
trimester or earlier, either self-reported, by interview or recorded in a 
medical report by measurement were included. 
2. Women with a pregnancy 
3. Primary observational studies 
In addition, we excluded studies: 
4. With a report of “maternal BMI” [17,19, 20, 21]. 
5. Without mention of BMI type (pre-pregnancy or maternal BMI) 
6. Those studies in which overweight was the reference group [22,23]. 
7. If they used a common data set in several studies. In these cases, a 
newer study with the most information was included in the analysis 
[13,24,25]. 2    
     
   
8. Also, the studies which had not reported the odds ratio (OR), relative 
risk (RR), hazard ratio (HR), confidence interval (CI) or standard 
error (SE), the percent or the number of initiation or intention of BF 
and the number of BMI in each category or inadequate data to 
calculate them 
9. Case reports, letter to editor and previous systematic reviews or meta-
analyses 
2.3. Screening and data extraction 
The relevant publications were reviewed independently by two au-
thors using EndNote X8 software. Discrepancies between authors were 
resolved by consensus or if they did not reach to agreement an expert 
provided the final result. Then, qualified studies were obtained for full-
text screening. The three authors extracted the information in order to 
identify eligible studies. After the final evaluation, the following infor-
mation was extracted: the name of the first author, date of publication, 
country, sample size, study design, the number of BMI group, percent or 
the number of initiation and intention of BF, mean or median duration of 
BF, crude and adjusted OR, RR & HR and 95% confidence interval (CI). 
For the purpose of this study, the dose (the mean for each BMI category) 
was calculated based on Najafi et al, study [26], so that, doses were 
defined as: 
BMI: 18.5–24.9 ¼ 21.7; BMI: 25–29.9 ¼ 27.45; BMI: 30–34.9 ¼ 
32.45; BMI: 35–39.9 ¼ 37.45 
BMI: 19.8–26 ¼ 22.9; BMI: 20–24.9 ¼ 22.4; BMI: 19–26 ¼ 22.5; BMI: 
26–29 ¼ 27.5; BMI: 30–39.9 ¼ 35; BMI: 40–49.9 ¼ 45 
BMI 20 ¼ 18.5; BMI<25 ¼ 21; BMI 25 ¼ 30; BMI<30 ¼ 23.7; 
BMI 30 ¼ 34.6; BMI 35 ¼ 38.5. Also, considering 18 for BMI 18.5, 41 
for BMI 40 and 51 for BMI 50. 
In addition, for those studies in which there was a report for number 
and/or percent of initiation/intention of BF by levels of BMI, we calcu-
lated the crude OR/RR [2,11,22,27,28,29,30,31,32]. In order to calcu-
late OR for the association between levels of BMI and BF, and if the 
authors used the non-initiation/intention group as reference, we calcu-
lated OR by the proportion of non-initiation/intention of BF to ini-
tiation/intention of BF (by using the reciprocal characteristic of OR) [1,7, 
27,33, 34, 35, 36, 37, 38, 39, 40, 41]. Also, in a study by Hilson et al. 
(2006) [42], we used values for adjusted ORs and RRs for a group of 
women “within IOM” as they placed normal-weight women (within IOM) 
as the reference group for all other strata and BMIs. 
All procedures performed in studies involving data extracted from 
articles were in accordance with the ethical standards of the Shahid 
Beheshti University of Medical Sciences research committee and with the 
1964 Helsinki declaration and its later amendments or comparable 
ethical standards. 
2.4. Quality assessment of studies 
The quality of included studies, was assessed using the Newcastle-
Ottawa quality assessment scale for cohort, case-control and cross-
sectional studies [43], based on criteria including: the type of study, 
sample size, participant selection, representativeness of the sample (case 
or expose group), adequacy of follow up, comparability and method of 
ascertainment for cases and controls. Finally, 40 studies with high and 
medium quality were included in the analyses. 
2.5. Statistical analysis 
The “metaprop” and “metan” command was performed to aggregate 
data from studies using Stata software (version 12) and fixed or random-
effects models were applied based on the degree of heterogeneity be-
tween the studies and significance of the Cochran's Q-test or a large 
Higgins and Thompson's I2 value. The cumulative meta-analysis was 
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32 studies with the effect of pre-pregnancy BMI 
on BF initiation, duration and intention BMI 
Figure 1. Flow diagram of the study selection process and including publications for the dose-response meta-analysis of pre-pregnancy BMI and breastfeeding 
initiation, intention and duration. performed using the “metacum” command and standard error for the 
prevalence of BF was calculated by the binomial distribution formula. 
The pooled effects of pre-pregnancy BMI levels (with 95% CI) on BF 
initiation, intention and duration were presented separately as odds ratio 
(OR), relative risk (RR) and hazard ratio (HR). In order to investigate the 
dose-response relationship, the two-stage random-effects meta-analysis 
was performed using the “dosresmeta” function in R software (version 
3.5.2). In this analysis, the studies which had not reported the percent or 
the number of BF initiation and the number of BMI in each level were 
excluded then linear, quadratic and cubic spline models were used to 
evaluate the relationship between pre-pregnancy BMI (dose) and BF 
initiation. Different models were fitted to the data and the best model 
was chosen according to the AIC and BIC. The dose-response analysis for Table 1. The overall prevalence of EBF and ABF by pre-pregnancy BMI (kg/m2) leve
Type of BF Underweight 
EBF Prevalence % 48.4 
95% CI 12.2–85.6 
No. of studies 6 
ABF Prevalence % 75.9 
95% CI 62.9–86.8 
No. of studies 3 
Not Reported Prevalence % 86 
95% CI 82.7–88.9 
No. of studies 9 
EBF and/or ABF Prevalence % 73.6 
95% CI 68.7–78.2 
No. of studies 18 
EBF ¼ Exclusive/Full Breastfeeding; ABF ¼ Any Breastfeeding. 
3 the duration of BF was not performed due to the low number of studies. 
In addition, the funnel plot, Begg's and Egger's test were applied to 
examine the publication bias using “metafunnel” and “metabias” com-
mand in Stata software. 
3. Results 
Consistent with standard meta-analysis techniques, the PRISMA 
guidelines, Up to April 2019, thirty-three studies with percent or number 
of initiation/intention or duration of BF and thirty-two studies with the 
effect of pre-pregnancy BMI on BF initiation, intention and duration were 
included in the present study (Figure 1). The studies were conducted in 
17 countries. More details about the studies are shown in Appendix 2. ls. 
Normal Overweight Obesity (Class I, II, III) 
61.6 53.9 37.8 
42.6–78.9 33.6–73.6 23.8–52.9 
24 20 30 
72.1 68.7 64.4 
63.5–79.9 60.4–76.3 59.4–69.2 
14 8 18 
86.5 77.3 71.8 
83.6–89.1 69.1–84.5 68.3–75.1 
27 28 29 
75.6 68.2 58.3 
72.2–78.9 61.8–74.3 55.2–61.4 
65 56 77 
Underweight - - - - 2 1a (0.84–1.19) 0.99 -
Normal - - - - 6 1 - -
Overweight - - - - 3 1.17a (1.05–1.31) 0.005 -
Obesity (Class I, II, III) - - - - 5 1.69a (1.43–2) <0.001 20.8 
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Table 2. The overall effect of pre-pregnancy BMI (kg/m2) on the cessation of EBF and ABF in BMI levels. 
BMI Categories Crude Odds Ratio Adjusted Odds Ratio 
No. of studies OR (95% CI) P for Heterogeneity I2 (%) No. of studies OR (95% CI) P for Heterogeneity I2 (%) 
1.14a (1.12–1.17) <0.0001 30.7 
1 - -
1.24b (1.14–1.34) 0.001 89.7 
1.47b (1.23–1.75) <0.0001 98.4 
BMI Categories Crude Relative Risk Adjusted Relative Risk 
No. of studies RR (95% CI) P for Heterogeneity I2 (%) No. of studies RR (95% CI) P for Heterogeneity I2 (%) 
1a (0.89–1.11) 0.98 39.6 
1 - -
1.05a (1.01–1.1) 0.01 24.4 
1.18a (1.03–1.36) 0.01 -
BMI Categories Crude Hazard Ratio Adjusted Hazard Ratio 
No. of studies HR (95% CI) P for Heterogeneity I2 (%) No. of studies HR (95% CI) P for Heterogeneity I2 (%) 
Underweight 25 1.3b (1.18–1.42) <0.0001 83.6 9 
Normal 68 1 - - 30 
Overweight 62 1.37b (1.10–1.70) <0.0001 99.6 29 
Obesity (Class I, II, III) 77 1.72b (1.56–1.89) <0.0001 96.3 28 
Underweight 18 1.18b (1.11–1.25) <0.0001 86.1 4 
Normal 55 1 - - 6 
Overweight 44 1.18b (1.03–1.35) <0.0001 99.6 6 
Obesity (Class I, II, III) 64 1.32b (1.25–1.40) <0.0001 96.1 4 
EBF ¼ Exclusive/Full Breastfeeding; ABF ¼ Any Breastfeeding. 
a Fixed effect model. 
b Random effect model. 3.1. The overall prevalence of BF initiation/intention by pre-pregnancy 
BMI levels 
EBF: The overall prevalence of EBF was 48.4, 61.6, 53.9, and 37.8% 
for underweight, normal, overweight and obese women, respectively 
(Table 1). 
ABF: The overall prevalence of ABF was 75.9, 72.1, 68.7, and 64.4% 
for underweight, normal, overweight and obese women, respectively 
(Table 1). 
Not Reported: The overall prevalence of BF in studies that did not 
report the type of BF was 86, 86.5, 77.3, and 71.8% for underweight, 
normal, overweight and obese women, respectively (Table 1). Underweight 1 0.97 (0.81–1.15) 0.72 
Normal 5 1 -
Overweight 5 1.04a (0.95–1.15) 0.33 
Obesity (Class I, II, III) 5 0.95a (0.85–1.06) 0.36 
Underweight 1 0.85 (0.62–1.16) 0.3 
Normal 4 1 -
Overweight 4 1.14a (1.05–1.25) 0.002 
Obesity (Class I, II, III) 2 1.22a (1.11–1.35) <0.0001 
BMI Categories Crude Relative Risk 
No. of studies RR (95% CI) P for Heterogeneity 
Underweight 2 1.27a (0.98–1.64) 0.06 
Normal 4 1 -
Overweight 4 1.02a (0.90–1.16) 0.69 
Obesity (Class I, II, III) 6 1.18b (0.93–1.49) 0.003 
Table 3. The overall effect of pre-pregnancy BMI (kg/m2) on the breastfeeding durat
BMI Categories Crude Odds Ratio 
No. of studies OR (95% CI) P for Heterogeneity 
BMI Categories Crude Hazard Ratio 
No. of studies HR (95% CI) P for Heterogeneity 
a Fixed effect model. 
b Random effect model. 
4 EBF and/or ABF: The overall prevalence of EBF and/or ABF was 
73.6, 75.6, 68.2, and 58.3% for underweight, normal, overweight and 
obesity, respectively (Table 1). 
3.2. The cumulative prevalence of BF initiation/intention among women 
Based on the cumulative meta-analysis, the trend of BF prevalence 
among underweight, normal, overweight and obese women decreased 
from 2001 to 2019. 
3.3. The overall effect of pre-pregnancy BMI on the risk of BF cessation 
Crude and adjusted odds ratio: The overall crude estimate for odds 
of BF cessation among underweight, overweight and obese women were - 3 0.96a (0.92–1.23) 0.04 12.9 
- 7 1 - -
- 7 1.08a (1.06–1.1) <0.001 39.1 
53.5 11 1.21b (1.12–1.31) <0.001 78 
- 1 0.84 (0.62–1.13) 0.25 53 
- 4 1 - -
- 4 1.07a (0.98–1.19) 0.13 50.2 
43.3 2 1.18a (1.06–1.32) 0.003 41.7 
Adjusted Relative Risk 
I2 (%) No. of studies RR (95% CI) P for Heterogeneity I2 (%) 
- 4 1.02a (0.95–1.09) 0.47 18.4 
- 6 1 - -
62.9 6 1.12b (1.02–1.22) <0.001 64.2 
69.9 6 1.26b (1.06–1.49) <0.001 55.9 
ion in BMI levels. 
Adjusted Odds Ratio 
I2 (%) No. of studies OR (95% CI) P for Heterogeneity I2 (%) 
Adjusted Hazard Ratio 
I2 (%) No. of studies HR (95% CI) P for Heterogeneity I2 (%) 
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Crude OR 
Adjusted OR 
Figure 2. The dose-response relationship of BMI (kg/m2) and risk of BF cessation based on the linear model and crude and adjusted OR; the solid line represents the 
fitted linear trend and dash line represents the 95% confidence interval. 1.3, 1.37, and 1.72, respectively. The corresponding values for adjusted 
OR were 1.14, 1.24, and 1.47, respectively (Table 2). 
Crude and adjusted relative risk: The overall crude estimate for the 
risk of BF cessation among underweight, overweight and obese women 
were 1.18, 1.18 and 1.32, respectively. The corresponding values for 
adjusted RR were 1, 1.05, and 1.18, respectively (Table 2). 
Adjusted hazard ratio: The adjusted hazard for BF cessation in un-
derweight, overweight and obese women were 1, 1.17, and 1.69, 
respectively (Table 2). 3.4. The overall effect of pre-pregnancy BMI on the risk of short-time BF 
Crude and adjusted odds ratio: The crude point estimate for odds of 
short-time BF among underweight, overweight and obese women were 
0.85, 1.14, and 1.22, respectively. The corresponding values for adjusted 
OR were 0.84, 1.07, and 1.18, respectively (Table 3). 
Crude and adjusted relative risk: The crude point estimate for the 
risk of short-time BF among underweight, overweight and obese women 
were 0.97, 1.04 and 0.95, respectively. The corresponding values for 
adjusted RR were 0.96, 1.08, and 1.21, respectively (Table 3). 
Crude and adjusted hazard ratio: The crude estimate of hazard for 
short-time BF among underweight, overweight and obese women were 
1.27, 1.02 and 1.18, respectively. The corresponding values for adjusted 
HR were 1.02, 1.12 and 1.26, respectively (Table 3). 5 3.5. Dose-response association between pre-pregnancy BMI and risk of BF 
cessation 
Using dose-response meta-analysis, there was a significant linear as-
sociation between risk of BF cessation and pre-pregnancy BMI. Based on 
crude and adjusted OR models, the risk of BF cessation increased by 4% 
(OR ¼ 1.04; 95% CI: 1.02–1.05) with an increase in a unit of BMI 
(Figure 2). In addition, based on crude and adjusted RR models, the risk 
of BF cessation increases by 2% and 1% (crude RR ¼ 1.02; 95% CI: 
1.01–1.03 and adjusted RR ¼ 1.01; 95% CI: 0.99–1.02) with an increase 
in one unit of BMI (Figure 3). 
3.6. Publication bias of risk of BF cessation in women 
The Begg's and Egger's test indicates that there is no publication bias 
in the present study (except in the crude odds ratio of the risk of BF 
cessation) (p > 0.05). 
4. Discussion 
More than one-third of women, aged over 18 years old, were classi-
fied as being overweight in 2016 [1,44], with many independent bodies 
projecting increases, globally, in the coming years [45,46]. Empirical 
data exists to suggest that women with pre-pregnancy underweight, 
overweight, and obesity, are less probable to initiate BF, and/or continue 
S.-S. Hashemi-Nazari et al. Heliyon 6 (2020) e05622 
Crude RR 
Adjusted RR 
Figure 3. The dose-response relationship of BMI (kg/m2) and risk of BF cessation based on the linear model and crude and adjusted RR; the solid line represents the 
fitted linear trend and dash line represents the 95% confidence interval. EBF, and/or any breastfeeding (ABF) [11, 12, 13, 14]. Previously, it has 
been reported that women with pre-pregnancy overweight and obesity 
were less likely to initiate BF and continue with EBF. However, such 
available evidence does not consider a dose-response association be-
tween maternal BMI and EBF/ABF [8,15, 16, 17, 18]. Therefore, in the 
present study, we sought to investigate the association between 
pre-pregnancy BMI and the persistence and duration of BF in a systematic 
review and dose-response meta-analyses. In accordance with the aim of 
this study, we found that the trend of BF prevalence among underweight, 
normal weight, overweight and obese women decreased from 2001 to 
2019, the lowest prevalence was related to overweight and obesity. 
Accordingly, overweight and obese women were more likely (in terms of 
relative risk, hazard ratio and odds ratio) to not initiate, or cease, 
EBF/ABF, as compared to normal-weight women. Furthermore, there 
was a significant linear association between risk of BF cessation and 
pre-pregnancy BMI, where the risk of BF cessation increased by 4% per 
1-unit increase of BMI. 
In a previous systematic review, Turcksin et al. (2014) reported that 
obese women plan to BF for a shorter period and are less likely to initiate 
and continue BF than normal-weight counterparts [16]; in the present 
study, this assertion was affirmed statistically, where we also incorpo-
rated a robust, hitherto unseen, dose-response meta-analysis. It is 
important to discern why adverse BF outcomes are more prevalent 
among overweight and obese women. One conceivable explanation re-
lates to the axiom that women with excess weight will have larger 6 breasts, which can act as a mechanical barrier, and therein have a 
negative impact on milk production, secretion and infant latching [47]. A 
significantly higher prevalence of obese women report difficulties BF, 
including cracked nipples, fatigue or difficulty initiating BF, whilst resi-
dent on the maternity ward, at 1- and 3-months post-partum, respec-
tively, in comparison with normal-weight counterparts [28]. Concerning 
milk supply, in comparison to normal-weight counterparts, obese women 
have a significantly lower milk transfer, more likely to perceive their milk 
supply as insufficient, and are more likely to report feeling uncomfortable 
BF at 3 months in social contexts [28]. The further putative explanation 
for the finding that overweight and obesity is associated with negative BF 
outcomes includes, that excessive adipose tissue acts as a reservoir of 
progesterone, and this can be an obstacle to the generation and secretion 
of lactogenesis II [42], which influences BF initiation [48]. However, in 
Garcia et al. (2016) it was reported that, in the overweight women, the 
indicative function of body fat was limited, suggesting that overweight 
may only have a limited impact on breastfeeding initiation [15]; 
although contrastingly, we found that even being classified as overweight 
was associated with negative BF outcomes. Further, having excess weight 
is associated with a plethora of injurious comorbidities, including the 
history of cesarean-section delivery, gestational diabetes, and post-
partum complications, which, coincidentally, are also strongly associated 
with poor BF outcomes [49]. In addition, increasing evidence indicates 
that the quantity and the quality of human milk may be, in part, modu-
lated by body composition [50], suggesting that problems associated 
S.-S. Hashemi-Nazari et al. Heliyon 6 (2020) e05622 with BF may be entwined with diet. Meyer et al. (2017) demonstrated 
that maternal diet significantly alters the milk microbiome, human milk 
oligosaccharides (HMO) composition, and abundance of gut-associated 
taxa [51]. Whilst postnatally, Burchenal et al. (2017) reported that the 
quality of carbohydrate consumed at 2-weeks and 4-months postpartum 
is associated with human breast milk quality, suggesting that modifiable 
factors, such as diet, may deleteriously impact bioactive components 
[52]. 
This systematic review and meta-analysis highlighted that over-
weight and obesity have negative associations with BF. In addition, there 
is also strong evidence to suggest that obesity is an independent cause of 
pregnancy and delivery complications, before BF has commenced, 
conceivably influencing intentions to BF [53, 54, 55, 56]. Although there 
is a paucity of data available on the associated cost induced by the 
pregnancy of obese women, Galtier-Dereure et al [55] reported that the 
cost for the obese mothers was five times higher than for the 
normal-weight mothers. Moreover, offspring of obese mothers have a 
higher risk for intrauterine fetal death [57,58], congenital abnormalities 
[57], head trauma, shoulder dystocia, brachial plexus lesions, fractures of 
the clavicle [59] and increased risk of mortality within the first year [60, 
61]; whilst paradoxically, BF is associated with the amelioration of many 
of these injurious pathologies. In this systematic review and 
meta-analysis, a number of negative BF outcomes are identified in obese 
women. Findings from this review suggest that health care professionals 
should consider obese women at risk for poor BF success and that they 
merit additional attention. To optimize the BF practice in overweight and 
obese women, health care professionals could facilitate additional edu-
cation and assistance for BF, starting before conception, and into the 
post-partum period. Breastfeeding promotion interventions and coun-
seling practices targeted at overweight and obese women specifically 
should be developed and tested for efficacy before implementation to 
ensure successful initiation and continuation of BF, notwithstanding, 
however, such interventions require tactful planning so to avoid 
weight-related stigma. 
4.1. Strengths and limitations 
The strengths of this review include that it reports the synthesis of the 
currently available evidence, whilst concurrently providing hitherto 
unseen quantitative evidence, in the form of a dose-response meta-
analysis, and contains a large, overall sample. Some limitations of this 
review also should be noted. The measurement of exposures and out-
comes include self-report values, and it has been reported that women 
often overstate their height and underreport their weight, which could 
yield inaccurate BMI reports. In addition, recall bias would be generated 
when BF was self-reported, and as such, it is conceivable that the asso-
ciation could be of greater magnitude considering that the exposures may 
be underestimated, and may have recall bias. Furthermore, an important 
point that needs to be highlighted is that BF is a cultural issue that varies 
among countries [62], and thus, more detailed, culturally specific trials 
must be conducted. 
4.2. Conclusions 
Findings from the present study suggest that BF rates are lowest in 
women who are overweight or obese, and there is a significantly greater 
hazard, relative risk, and odds ratio, respectively, for overweight and 
obese women to not initiate, or cease, EBF/ABF. Finally, we found that 
there is a significant linear association between risk of BF cessation and 
pre-pregnancy BMI, where the risk of BF cessation increases by 4% per 1-
unit increase of BMI. Clearly, the influence of excessive weight on BF is 
multifaceted, with psychological, physiological, emotional and me-
chanical barriers all, likely, having mediating roles. Health care pro-
fessionals and other key stakeholders should be aware of the impact 7 excess weight, and that women who are overweight or obese should be 
encouraged with continued access to guidance, counseling and support, 
starting from conception, to maximize BF outcomes. 
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